Summary
A U.S. advisory panel recommended limiting the combined MMRV vaccine for young children due to seizure concerns, suggesting separate shots instead. The panel also debated changing who should get the Hepatitis B vaccine at birth but delayed the final decision. These recommendations will need approval from the CDC before taking effect.
Key Facts
- The advisory panel voted to limit the use of the combined MMRV vaccine in children under 4, advising separate shots for measles, mumps, rubella, and varicella.
- The recommendation was based on concerns about the risk of seizures in younger children.
- Health insurers may stop covering the MMRV vaccine for kids under four, but a federal program may continue to do so.
- The panel discussed delaying the Hepatitis B vaccine for most newborns if their mothers do not test positive for the virus, with a vote to follow.
- Hepatitis B vaccinations protect against serious liver-related health issues.
- A significant number of pregnant women in the U.S. go unscreened for Hepatitis B, leading to potential gaps in vaccination.
- Medical groups expressed concerns that the panel was not using enough data in their deliberations, and some believe it could lead to misinformation.
- CDC approval is needed for these recommendations to become policy.
